Lichen International Limited
LICN
$4.41
$0.11912.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 41.48M | 41.70M | 41.93M | 40.84M | 39.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.48M | 41.70M | 41.93M | 40.84M | 39.76M |
| Cost of Revenue | 15.80M | 16.14M | 16.47M | 15.96M | 15.44M |
| Gross Profit | 25.67M | 25.57M | 25.46M | 24.89M | 24.32M |
| SG&A Expenses | 30.23M | 22.29M | 14.35M | 13.20M | 12.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.03M | 38.42M | 30.82M | 29.16M | 27.50M |
| Operating Income | -4.55M | 3.28M | 11.11M | 11.68M | 12.26M |
| Income Before Tax | -4.17M | 3.52M | 11.20M | 11.40M | 11.59M |
| Income Tax Expenses | 1.95M | 2.70M | 3.45M | 3.35M | 3.25M |
| Earnings from Continuing Operations | -6.12 | 0.81 | 7.75 | 8.04 | 8.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -19.00K | -9.50K | -- | -- | -- |
| Net Income | -6.14M | 804.50K | 7.75M | 8.04M | 8.34M |
| EBIT | -4.55M | 3.28M | 11.11M | 11.68M | 12.26M |
| EBITDA | -3.75M | 4.00M | 11.75M | 12.38M | 13.01M |
| EPS Basic | -28.84 | 14.50 | 57.83 | 60.55 | 63.26 |
| Normalized Basic EPS | -10.94 | 20.49 | 51.92 | 53.46 | 54.99 |
| EPS Diluted | -28.84 | 14.50 | 57.83 | 60.55 | 63.26 |
| Normalized Diluted EPS | -10.94 | 20.49 | 51.92 | 53.46 | 54.99 |
| Average Basic Shares Outstanding | 703.60K | 633.00K | 562.40K | 541.90K | 521.40K |
| Average Diluted Shares Outstanding | 703.60K | 633.00K | 562.40K | 541.90K | 521.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |